Amoxicillin/clavulanic acid 2000/125 mg to prevent complications due to infection following completely bone-impacted lower third molar removal: a clinical trial

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jan;119(1):8-16. doi: 10.1016/j.oooo.2014.08.014. Epub 2014 Sep 16.

Abstract

Objective: The purpose of this study was to determine the effect of amoxicillin/clavulanic acid to prevent infection following completely bone-impacted lower third molar removal.

Study design: A random, double-blind placebo-controlled clinical trial including 118 adults randomly allocated to placebo (60 patients) or antibiotic treatment (58 patients): 2 g amoxicillin/125 mg clavulanic acid 2 hours before the surgery and post-operatively twice a day for 4 days. Infection was clinically assessed until 8 weeks after surgery. Adverse events, as well as clinical and surgical variables, were recorded. Analysis was by intention to treat.

Results: Infections developed in five patients in the placebo group, all in the first postoperative week, and in two in the antibiotic group, both after the first week, the difference not being statistically significant (P = .278, number needed to treat 19 [8-∞]). There were no relationships between any variables studied and infection. No serious adverse events were reported.

Conclusion: There is insufficient evidence to recommend routine use of this antibiotic treatment.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Molar, Third / surgery*
  • Placebos
  • Postoperative Care
  • Surgical Wound Infection / prevention & control*
  • Tooth Extraction
  • Tooth, Impacted / surgery*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Placebos
  • Amoxicillin-Potassium Clavulanate Combination